ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Waverley Pharma, Inc. ?
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Operating profit has grown by an annual rate 3.71% of over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -0.81
2
Negative results in Mar 26
- NET SALES(HY) At CAD 0.58 MM has Grown at -30.81%
- RAW MATERIAL COST(Y) Grown by 18.13% (YoY)
- PRE-TAX PROFIT(Q) At CAD -0.17 MM has Fallen at -33.02%
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 25.00%, its profits have risen by 9%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Waverley Pharma, Inc. for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Waverley Pharma, Inc.
-100.0%
0.14
181.20%
S&P/TSX 60
29.63%
2.23
12.57%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-2.24%
EBIT Growth (5y)
3.71%
EBIT to Interest (avg)
-0.70
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.32
Sales to Capital Employed (avg)
0.76
Tax Ratio
0.26%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-0.50
EV to EBIT
-4.65
EV to EBITDA
-4.65
EV to Capital Employed
4.65
EV to Sales
3.73
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-45.26%
ROE (Latest)
Negative BV
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bullish
Bullish
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend2What is working for the Company
NET PROFIT(HY)
Higher at CAD -0.36 MM
-14What is not working for the Company
NET SALES(HY)
At CAD 0.58 MM has Grown at -30.81%
RAW MATERIAL COST(Y)
Grown by 18.13% (YoY
PRE-TAX PROFIT(Q)
At CAD -0.17 MM has Fallen at -33.02%
NET PROFIT(Q)
At CAD -0.17 MM has Fallen at -32.59%
Here's what is not working for Waverley Pharma, Inc.
Net Sales
At CAD 0.58 MM has Grown at -30.81%
Year on Year (YoY)MOJO Watch
Near term sales trend is very negative
Net Sales (CAD MM)
Pre-Tax Profit
At CAD -0.17 MM has Fallen at -33.02%
over average net sales of the previous four periods of CAD -0.12 MMMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (CAD MM)
Net Profit
At CAD -0.17 MM has Fallen at -32.59%
over average net sales of the previous four periods of CAD -0.12 MMMOJO Watch
Near term Net Profit trend is negative
Net Profit (CAD MM)
Raw Material Cost
Grown by 18.13% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
